G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs-Reference-Cited by-同舟云学术

G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs

Published:1998-02 Issue:4 Volume:21 Page:401-407
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tarella C,Castellino C,Locatelli F,Caracciolo D,Corradini P,Falda M,Novarino A,Tassi V,Pileri A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1701104.pdf

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the Utility of Granulocyte Colony-Stimulating Factor Post-Autologous Hematopoietic Stem Cell Transplantation for Outpatient-Based Transplantations;Transplantation and Cellular Therapy;2023-11

2. A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation;Italian Journal of Pediatrics;2018-05-31

3. Pegfilgrastim: More Cost Effective and Equally Efficacious Option as Compared to Filgrastim in Autologous Stem Cell Transplant;Indian Journal of Hematology and Blood Transfusion;2018-05-17

4. Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices;Biology of Blood and Marrow Transplantation;2018-02

5. Daily vs every other day administration of G-CSF following autologous peripheral stem cell transplantation: A prospective randomized study;Transfusion and Apheresis Science;2013-10